company background image

ECO Animal Health Group AIM:EAH Stock Report

Last Price


Market Cap







30 Sep, 2022


Company Financials +
EAH fundamental analysis
Snowflake Score
Future Growth4/6
Past Performance0/6
Financial Health6/6

EAH Stock Overview

ECO Animal Health Group plc, together with its subsidiaries, develops, registers, and markets pharmaceutical products for animals worldwide.

ECO Animal Health Group plc Competitors

Price History & Performance

Summary of all time highs, changes and price drops for ECO Animal Health Group
Historical stock prices
Current Share PriceUK£1.19
52 Week HighUK£3.26
52 Week LowUK£0.81
1 Month Change32.96%
3 Month Change5.31%
1 Year Change-62.22%
3 Year Change-66.29%
5 Year Change-81.02%
Change since IPO257.00%

Recent News & Updates

Shareholder Returns

EAHGB PharmaceuticalsGB Market

Return vs Industry: EAH underperformed the UK Pharmaceuticals industry which returned -5.1% over the past year.

Return vs Market: EAH underperformed the UK Market which returned -16.2% over the past year.

Price Volatility

Is EAH's price volatile compared to industry and market?
EAH volatility
EAH Average Weekly Movement8.2%
Pharmaceuticals Industry Average Movement6.7%
Market Average Movement5.4%
10% most volatile stocks in GB Market10.7%
10% least volatile stocks in GB Market2.8%

Stable Share Price: EAH is more volatile than 75% of UK stocks over the past 3 months, typically moving +/- 8% a week.

Volatility Over Time: EAH's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of UK stocks.

About the Company

1972221David Hallas

ECO Animal Health Group plc, together with its subsidiaries, develops, registers, and markets pharmaceutical products for animals worldwide. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites, such as worms, ticks, mange, and lices in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle.

ECO Animal Health Group plc Fundamentals Summary

How do ECO Animal Health Group's earnings and revenue compare to its market cap?
EAH fundamental statistics
Market CapUK£80.59m
Earnings (TTM)-UK£686.00k
Revenue (TTM)UK£82.20m


P/S Ratio


P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
EAH income statement (TTM)
Cost of RevenueUK£47.06m
Gross ProfitUK£35.14m
Other ExpensesUK£35.82m

Last Reported Earnings

Mar 31, 2022

Next Earnings Date


Earnings per share (EPS)-0.01
Gross Margin42.75%
Net Profit Margin-0.83%
Debt/Equity Ratio0%

How did EAH perform over the long term?

See historical performance and comparison